Innocoll Technologies Ltd - Product Pipeline Analysis, Update 2014

Call 866-997-4948 (Us-Canada Toll Free) Tel: +1-518-618-1030 with your industry research requirements or email the details on sales@researchmoz.us

Innocoll Technologies Ltd - Product Pipeline Analysis, Update 2014

Summary

Innocoll Technologies Ltd (Innocoll Technologies) is a biopharmaceutical company. The company develops and markets pharmaceutical products and medical devices for the pharmaceutical and medical markets. Its products include cogenzia, xaracoll, gentamicin surgical implant, procoll, and durieva. Innocoll Technologies approved products include zorprevasurgical haemostat, collacare family, gentamicin surgical implant, collexa, lidocoll, collaguard adhesion barrier, and innocoll dental. The companys products are used in a variety of medical applications such as preventing surgical adhesions in the treatment of post-operative or post-traumatic pain or inflammation and treating deep wounds such as ulcers, burns, and acute trauma injuries. It partners with Baxter, EUSA pharma, Merus labs, curesys, KMA, and Pioneer Pharma. Innocoll Technologies is headquartered in Athlone, Ireland.

To Browse a Full Report with Toc: http://www.researchmoz.us/innocoll-technologies-ltd-product-pipeline-analysis-2014-update-report.html

This report is a source for data, analysis, and actionable intelligence on the companys portfolio of pipeline products. The report provides key information about the company, its major products and brands.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Innocoll Technologies Ltd

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed...